Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13

GLIA

Volumn 62, Issue 9, 2014, Pages 1452-1462

  Esen, Nilufer ^a   Rainey Barger, Emily K ^a   Huber, Amanda K ^a   Blakely, Pennelope K ^a   Irani, David N ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

CXCL13; IRF7; Microglia; Type I interferon

Indexed keywords

CXCL13 CHEMOKINE; CXCL13 PROTEIN, MOUSE; INTERFERON; INTERFERON REGULATORY FACTOR 7; IRF7 PROTEIN, MOUSE; TOLL LIKE RECEPTOR;

ALPHAVIRUS INFECTION; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; ENCEPHALOMYELITIS; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; KNOCKOUT MOUSE; METABOLISM; MICROGLIA; PHYSIOLOGY; SINDBIS VIRUS; VIRUS ENCEPHALITIS;

ALPHAVIRUS INFECTIONS; ANIMALS; BRAIN; CELLS, CULTURED; CHEMOKINE CXCL13; DISEASE MODELS, ANIMAL; ENCEPHALITIS, VIRAL; ENCEPHALOMYELITIS; INTERFERON REGULATORY FACTOR-7; INTERFERON TYPE I; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; NEUROIMMUNOMODULATION; SINDBIS VIRUS; TOLL-LIKE RECEPTORS;

EID: 84904305801     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22692     Document Type: Article

References (50)

1. Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N, Cyster JG. 2004. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 5:943-952.
2. Aloisi F, Columba-Cabezas S, Franciotta D, Rosicarelli B, Magliozzi R, Reynolds R, Ambrosini E, Salvetti M, Serafini B. 2008. Lymphoid chemokines in chronic neuroinflammation. J Neuroimmunol 198:106-112.
3. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster JD, Sedgwick JD, Browning JL, Lipp M, Cyster JG. 2000. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406:309-314.
4. Bagaeva LV, Rao P, Powers JM, Segal BM. 2006. CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J Immunol 176:7676-7685.
5. Beutner C, Linnartz-Gerlach B, Schmidt SV, Beyer M, Mallmann MR, Staratschek-Jox A, Schultzw JL, Neumann H. 2013. Unique transcriptome signature of mouse microglia. Glia 61:1429-1442.
6. Brettschneider J, Czerwoniak A, Senel M, Fang L, Kassubek J, Pinkhardt E, Lauda F, Kapfer T, Jesse S, Lehmensiek V, Ludolph AC, Otto M, Tumani H. 2010. The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS) PLoS One 5:e11986.
7. Campbell DJ, Kim CH, Butcher EC. 2003. Chemokines in the systemic organization of immunity. Immunol Rev 195:58-71.
8. Cucak H, Yrlid U, Reizis B, Kalinke U, Johansson-Lindbom B. 2009. Type I interferon signaling in dendritic cells stimulates the development of lymph node-resident T follicular helper cells. Immunity 31:491-501.
9. Cufi P, Dragin N, Ruhlmann N, Weiss JM, Fadel E, Serraf A, Berrih-Aknin S, Le Panse R. 2013. Central role of interferon-beta in thymic events leading to myasthenia gravis. J Autoimmun. http://dx.doi.orp/10.1016/j.aut.2013.12.016.
10. Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, Lynch KR, Kipnis J. 2010. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 207:1067-1080.
11. Esen N, Kielian T. 2005. Recognition of staphylococcus aureus-derived peptidoglycan but not intact bacteria is mediated by CD14 in microglia. J Neuroimmunol 170:93-104.
12. Forster R, Matis AE, Kremmer E, Wolf E, Brem G, Lipp M. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-1047.
13. Fu Y-X, Chaplin DD. 1999. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 17:399-433.
14. Hjelmstrom P. 2001. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 69:331-339.
15. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777.
16. Irani DN, Prow NA. 2007. Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis. J Neuropathol Exp Neurol 66:533-544.
17. Khademi M, Kockum I, Andersson ML, Iacobaeus E, Brundin L, Sellebjerg F, Hillert J, Piehl F, Olsson T. 2011. Cerebrospinal fluid CXCL13 in multiple sclerosis: A suggestive prognostic marker for the disease course. Mult Scler 17:335-343.
18. Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, Newcombe J, Hohlfeld R, Meinl E. 2006. Chemokines in multiple sclerosis: CXCR12 and CXCR13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 129:200-211.
19. Lalor SJ, Segal BM. 2010. Lymphoid chemokines in the CNS. J Neuroimmunol 224:56-61.
20. Legler DF, Loetscher M, Roos R, Clark-Lewis I, Baggiolini M, Moser B. 1998. B-cell attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 187:655-660.
21. Liang XH, Goldman JE, Jiang HH, Levine B. 1999. Resistance of interleukin-1β-deficient mice to fatal Sindbis virus encephalitis. J Virol 73:2563-2567.
22. Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG. 2000. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12:471-481.
23. Mackay F, Browning JL. 1998. Turning off follicular dendritic cells. Nature 395:26-27.
24. McManus CM, Liu JS, Hahn MT, Hua LL, Brosnan CF, Berman JW, Lee SC. 2000. Differential induction of chemokines in human microglia by type I and type II interferons. Glia 29:273-280.
25. Magliozzi R, Columba-Cabezas S, Serafini B, Aloisi F. 2004. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 148:11-23.
26. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Popolo M, Reynolds R, Aloisi F. 2007. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130:1089-1104.
27. Mazzucchelli L, Blaser A, Kappeler A, Scharli P, Laissue JA, Baggiolini M, Uguccioni M. 1999. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 104:49-54.
28. Moser B, Schaerli P, Laetscher P. 2002. CXCR5+ T cells: follicular homing takes center stage in T-helper-cell responses. Trends Immunol 23:250-254.
29. Mueller SN, Hosiawa-Meagher KA, Konieczny BT, Sullivan BM, Bachmann MF, Locksley RM, Ahmed R, Matloubian M. 2007. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317:670-674.
30. Muller G, Hopken UE, Lipp M. 2003. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 195:117-135.
31. Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD, Browning JL, Sedgwick JD, Cyster JG. 1999. Lymphotoxin-α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med 189:403-412.
32. Ning S, Pagano JS, Barber GN. 2011. IRF7: activation, regulation, modification and function. Genes Immun 12:399-414.
33. Peters A, Pitcher LA, Sullivan JM, Mitsdoerffer M, Acton SE, Franz B, Wucherpfennig K, Turley S, Carroll MC, Sobel RA, Bettelli E, Kuchroo VK. 2011. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35:986-996.
34. Phares TW, Stohlman SA, Bergmann CC. 2013. Intrathecal humoral immunity to encephalitic RNA viruses. Viruses 5:732-752.
35. Piccio L, Naismith RT, Trinkaus K, Klein RS, Parks BJ, Lyons JA, Cross AH. 2010. Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Arch Neurol 67:707-714.
36. Prow NA, Irani DN. 2007. The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis. Exp Neurol 205:461-470.
37. Publicover J, Gaggar A, Nishimura S, Van Horn CM, Goodsell A, Muench MO, Reinhardt RL, van Rooijen N, Wakil AE, Peters M, Cyster JG, Erle DJ, Rosenthal P, Cooper S, Baron JL. 2013. Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest 123:3728-3739.
38. Ragheb S, Li Y, Simon K, Vanhaerents S, Galimberti D, De Riz M, Fenoglio C, Scarpini E, Lisak R. 2011. Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid. Mult Scler 17:819-829.
39. Rainey-Barger EK, Rumble JM, Lalor SJ, Esen N, Segal BM, Irani DN. 2011. The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system. Brain Behav Immun 25:922-931.
40. Ramesh G. Borda JT, Dufour J, Kaushal D, Ramamoorthy R, Lackner AA, Philipp MT. 2008. Interaction of the Lyme disease spirochete Borrelia bergdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. Am J Pathol 173:1415-1427.
41. Rangel-Moreno J, Moyron-Quiroz JE, Hartson L, Kusser K, Randall TD. 2007. Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza. Proc Natl Acad Sci USA 104:10577-10582.
42. Schreiber G. 2002. The evolution of transthyretin synthesis in the choroid plexus. Clin Chem Lab Med 40:1200-1210.
43. Sellebjerg F, Bornsen L, Khademi M, Krakauer M, Olsson T, Frederiksen JL, Sorensen PS. 2009. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology 73:2003-2010.
44. Serafini B, Rosicarelli B, Magiozzi R, Aloisi F. 2004. Detection of ectopic B-cell follicles with germinal centers in meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14:164-174.
45. Tucker PC, Griffin DE, Choi S, Bui N, Wesselingh S. 1996. Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis. J Virol 70:3972-3977.
46. Tyor WR, Wesselingh S, Levine B, Griffin DE. 1992. Long term intraparenchymal Ig secretion after acute viral encephalitis in mice. J Immunol 149:4016-4020.
47. Yamamoto K, Nishiumi S, Yang L, Klimatcheva E, Pandina T, Takahashi S, Matsui H, Nakamura M, Zauderer M, Yoshida M, Azuma T. 2014. Anti-CXCL13 antibody can inhibit the formation of gastric lymphoid follicles induced by Helicobacter infection. Mucosal Immunol. doi:10.1038/mi.2014.14. [Epub ahead of print]
48. Yoshie O, Imai T, Nomiyama H. 1997. Novel lymphocyte-specific CC chemokines and their receptors. J Leukoc Biol 62:634-644.
49. Zhong X, Wang H, Dai Y, Wu A, Bao J, Xu W, Cheng C, Lu Z, Qiu W, Hu X. 2011. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica. J Neuroimmunol 241:104-108.
50. Zlotnik A, Morales J, Hedrick JA. 1999. Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 19:1-47.